View Older Stories
-
Merit Medical Systems, Inc. (MMSI) PT Lowered to $96 at Piper Sandler
-
Merit Medical Systems, Inc. (MMSI) PT Lowered to $90 at Canaccord
-
BTIG Merit Medical Systems, Inc. (MMSI): View Point acquisition a 'nice strategic fit'
-
BTIG stays Buy on Merit Medical Systems, Inc. (MMSI): 'pleased to see' ViaVerte agreement with MDT
-
Medtronic partners with Merit Medical to distribute ViaVerte back pain system
-
Piper Sandler's Top Medical Technology Picks Exiting 4Q-25 EPS Season
-
Piper Sandler: 'When Will Things Turn in Med Tech and What Names to Own Now?'
-
Wells Fargo Downgrades Merit Medical Systems, Inc. (MMSI) to Equal Weight
-
Merit Medical Systems, Inc. (MMSI) PT Lowered to $101 at Needham
-
Merit Medical Systems Inc. (MMSI) Tops Q4 EPS by 9c ; Offers Guidance
-
Merit Medical Systems, Inc. (MMSI) PT Lowered to $106 at Piper Sandler
-
BTIG Starts Merit Medical Systems, Inc. (MMSI) at Buy
-
Merit Medical appoints F. Ann Millner as chair, reports Q4 revenue growth
-
Merit Medical Systems, Inc. (MMSI) PT Lowered to $93 at Canaccord Genuity
-
Merit Medical withdraws reimbursement application, pivots strategy
-
Merit Medical reports 24-month data showing device outperforms angioplasty
-
Merit Medical reports 24-month results from arteriovenous graft trial
-
Merit Medical Systems Inc. (MMSI) Tops Q3 EPS by 9c, provides guidance
-
Merit Medical Systems, Inc. (MMSI) PT Raised to $104 at Canaccord Genuity
-
PENTAX Medical sells C2 CryoBalloon product line to Merit Medical Systems
-
Piper Sandler Reiterates Overweight Rating on Merit Medical Systems, Inc. (MMSI)
-
Merit Medical reaches 750,000 patients treated with SCOUT technology
-
Merit Medical launches hydrophilic sheath with securement technology
-
Needham Reiterates Buy Rating on Merit Medical Systems, Inc. (MMSI)
-
Merit Medical Systems Inc. (MMSI) Tops Q2 EPS by 16c ; Offers Guidance
-
Piper Sandler Reiterates Overweight Rating on Merit Medical Systems, Inc. (MMSI)
-
Needham Reiterates Buy Rating on Merit Medical Systems, Inc. (MMSI)
-
Merit Medical names Martha Aronson as president and CEO
-
Piper Sandler: 'Why Are Merit Medical Systems, Inc. (MMSI) Insiders Selling?'
-
Merit Medical Systems, Inc. (MMSI) PT Raised to $112 at Canaccord Genuity
-
Merit Medical Systems Inc. (MMSI) Acquires Biolife Delaware
-
Merit Medical Systems Inc. (MMSI) Announces Health Canada Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
-
Merit Medical Systems Inc. (MMSI) Releases 12-Month Efficacy Results for the Single-Arm Arteriovenous Graft Cohort of the WRAPSODY WAVE Trial
-
Merit Medical Systems, Inc. (MMSI) PT Lowered to $100 at Needham
-
Merit Medical Systems Inc. (MMSI) Tops Q1 EPS by 11c, Beats on Revenue; Offers FY25 Guidance
-
Merit Medical Systems (MMSI) Launches the Ventrax Delivery System
-
Merit Medical Systems Inc. (MMSI) Drops Below $100, Bofa Comments: 'MMSI is likely most exposed with 11% of sales from China and no China manufacturing'
-
JPMorgan Starts Merit Medical Systems, Inc. (MMSI) at Overweight
-
Merit Medical Systems (MMSI) Releases 12-Month Efficacy Results of the WRAPSODY Cell-Impermeable Endoprosthesis
-
Merit Medical Systems, Inc. (MMSI) PT Lowered to $116 at Oppenheimer
-
Merit Medical Systems, Inc. (MMSI) PT Lowered to $116 at Needham
-
Merit Medical Systems, Inc. (MMSI) PT Raised to $116 at Raymond James
-
Merit Medical Systems Inc. (MMSI) Tops Q4 EPS by 11c, provides guidance
-
Merit Medical Systems, Inc. (MMSI) PT Raised to $122 at Needham
-
Merit Medical Systems, Inc. (MMSI) PT Raised to $114 at Piper Sandler; 'MMSI Continues to be One of our Top Ideas'
-
Needham Reiterates Buy Rating on Merit Medical Systems, Inc. (MMSI)
-
Merit Medical Systems, Inc. (MMSI) PT Raised to $110 at Raymond James
-
Canaccord Genuity Reiterates Buy Rating on Merit Medical Systems, Inc. (MMSI)
-
Merit Medical Systems Inc. (MMSI) Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis
-
Medical Technology and Devices: Piper Sandler Shares 'Quick Thoughts on HC Conference in Jan'

